Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma-Reference-Cited by-同舟云学术

Current and potential immunohistochemical biomarkers for prognosis and therapeutic stratification of breast carcinoma

Published:2021-07 Issue: Volume:72 Page:114-122
ISSN:1044-579X
Container-title:Seminars in Cancer Biology
language:en
Short-container-title:Seminars in Cancer Biology

Author:

Ronchi Andrea,Pagliuca Francesca,Zito Marino Federica,Accardo Marina,Cozzolino Immacolata,Franco Renato

Publisher

Elsevier BV

Subject

Cancer Research

Reference91 articles.

1. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods;Kinsel;Cancer Res.,1989

2. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro;Ogawa;Biochem. Biophys. Res. Commun.,1998

3. What’s new in estrogen receptor action in the female reproductive tract;Hewitt;J. Mol. Endocrinol.,2016

4. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer;McDonnell;Curr. Opin. Pharmacol.,2010

5. The ligand‐mediated nuclear mobility and interaction with estrogen‐responsive elements of estrogen receptors are subtype specific;Muyan;J. Mol. Endocrinol.,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Proapoptotic Action of Pyrrolidinedione–Thiazolidinone Hybrids towards Human Breast Carcinoma Cells Does Not Depend on Their Genotype;Cancers;2024-08-22

2. High-Plex Assessment of Biomarkers in Tumors;Modern Pathology;2024-03

3. Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy;Journal of Biophotonics;2024-01-28

4. Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling;Biomarker Research;2024-01-25

5. Rare axillary cancer of unknown primary originating from the breast of a 64‑year‑old male patient: A case report and literature review;Oncology Letters;2024-01-05